The distinct functions of the individual CFHR proteins within the entire cascade indicate that individuals with CFH gene abnormalities might find therapeutic value in one of the emerging complement inhibitor and clinical trials of complement therapy for glomerular diseases are also underway42. This evidence concerns the gene CFH and glomerular disorder.